Company
Arima Genomics
Arima Genomics is building DNA-based cancer diagnostics that bring sequence and structure together to find more of what drives disease — creating new opportunities to guide therapy and bring more patients closer to the right treatment.
Also known as Arima Genomics, Inc.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Customers
- clinicians and biopharma teams
- Legal name
- Arima Genomics, Inc.
Claim, correct or request removal
Record updated 18 September 2026
About
Arima Genomics was founded by leaders in 3D genome science and built on the belief that genome structure holds critical information about disease. Today, Arima applies that expertise through Aventa clinical tests, biopharma partnerships, and platform innovation — redefining cancer diagnostics by revealing more of what drives disease and advancing a more complete DNA-based view of cancer.
Products
- Other
- Aventa FusionPlus
- Other
- Aventa Lymphoma
Loading relationship preview